Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Please note: We are reviewing Western blot images included in the antibody testing data in our catalog, including those provided by third parties. Unless expressly labeled or annotated as “raw-unedited”, Western blot images included in the antibody testing data in our catalog may have been edited, optimized or otherwise adjusted for presentation.
Sulfa II is a biosimilar derived from sulfonamide compounds, which are known for their antibacterial properties. The biosimilar is synthesized through complexation with metal ions such as Mn(II) and Cu(II), forming Schiff bases with sulfamethoxazole. These complexes exhibit unique coordination modes and geometries, which are determined through various analytical techniques including emission atomic spectroscopy and magnetic measurements. Sulfa II's structure allows it to act as a multi-target agent, showing potential in treating complex diseases like cancer due to its anti-proliferative activities. The biosimilar's functionality is enhanced by its ability to interact with biological systems, offering promising therapeutic applications. Synonyms for Sulfa II include sulfamethoxazole complex, sulfonamide derivative, Mn(II) Schiff base, Cu(II) complex, antibacterial agent, multi-target compound, anti-proliferative agent, and metal-sulfa complex.
仅用于科研。不用于诊断过程。未经明确授权不得转售。